| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/09/2013 | CN102863516A Production of cell-penetrating peptide hPP10 (human Pancreatic Polypeptide) and transfection method for mediated plasmid DNA (Deoxyribose Nucleic Acid) of hPP10 |
| 01/09/2013 | CN102863515A B-cell epitope of human melanoma antigen MAGE-A3 and application thereof |
| 01/09/2013 | CN102863514A Peptide vaccines for cancers expressing tumor-associated antigens |
| 01/09/2013 | CN102863513A Preparation method of desmopressin acetate |
| 01/09/2013 | CN101921319B Rubiaceae-type cyclopeptides, medicinal compositions using same as active ingredients, and preparation method and application thereof |
| 01/09/2013 | CN101906150B Preparation method of Bivalirudin |
| 01/09/2013 | CN101885759B Polypeptide capable of specifically bonding porcine reproductive and respiratory syndrome viruses, screening method thereof and use thereof |
| 01/08/2013 | US8349805 Use of Gonadorelin as a therapeutic agent |
| 01/08/2013 | US8349801 Peptide ligands for G-protein coupled receptors |
| 01/08/2013 | US8349791 Polypeptides that bind membrane proteins |
| 01/08/2013 | US8349576 eEF2K assays for identifying compounds that inhibit eEF2K activity |
| 01/08/2013 | CA2683610C Suspension formulations of insulinotropic peptides and uses thereof |
| 01/08/2013 | CA2605078C Plant-derived elastin binding protein ligands and methods of using the same |
| 01/08/2013 | CA2223608C Vaccine for porcine reproductive and respiratory syndrome virus |
| 01/03/2013 | WO2013003178A1 Sulfation of wnt pathway proteins |
| 01/03/2013 | WO2013001297A1 Binding inhibitors of the beta.transducin repeat - containing protein |
| 01/03/2013 | WO2013000922A1 Ccr2 antagonist peptides |
| 01/03/2013 | WO2013000568A1 Method of obtaining a binder to prepro-vasopressin or fragments thereof |
| 01/03/2013 | WO2012148720A3 Anti-microbial peptides and methods of use thereof |
| 01/03/2013 | WO2012145680A3 Anti-microbial peptides and uses therefore |
| 01/03/2013 | WO2012101599A3 Glycogen synthase kinase-3 inhibitors |
| 01/03/2013 | WO2012087913A3 Peptide reagents and methods for detection of colon dysplasia |
| 01/03/2013 | WO2012078060A3 Peptide preparations and peptides with antitumour activity |
| 01/03/2013 | US20130005944 CXCR4 Receptor Compounds |
| 01/03/2013 | US20130005943 Methods for Preparing Internally Constrained Peptides and Peptidomimetics |
| 01/03/2013 | US20130005833 Photo-responsive supramolecular hydrogels |
| 01/03/2013 | US20130005644 Cyclic agonists and antagonists of c5a receptors and g protein-coupled receptors |
| 01/03/2013 | US20130004941 Proteinase k inhibitors, methods and compositions therefor |
| 01/03/2013 | US20130004531 Immunogens from uropathogenic escherichia coli |
| 01/03/2013 | US20130004528 Direct analysis of antigen-specific immune response |
| 01/03/2013 | US20130004423 Polyazamacrocyclic compound, and a production method and a biomedical use therefor |
| 01/03/2013 | US20130004415 Joint-Homing Peptides and Uses Thereof |
| 01/03/2013 | CA2838290A1 Sulfation of wnt pathway proteins |
| 01/02/2013 | EP2541252A1 Method of obtaining a binder to prepro-vasopressin or fragments thereof |
| 01/02/2013 | EP2540739A1 Oligopeptide improving differentiation of osteoblasts |
| 01/02/2013 | EP2540736A2 Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity |
| 01/02/2013 | EP2540735A2 Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity |
| 01/02/2013 | EP2538964A1 Modulation of cytokine-induced chronic inflammatory responses |
| 01/02/2013 | CN1454215B Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/02/2013 | CN102858794A Peptides whose uptake in cells is controllable |
| 01/02/2013 | CN102858793A Affinity Peptides Toward Bmp-2 |
| 01/02/2013 | CN102850441A Solid-phase synthetic method of oxytocin |
| 01/02/2013 | CN102850440A Chemical synthesis method of sinapultide |
| 01/02/2013 | CN102850439A Hepatitis B virus surface antigen (HBsAg) binding polypeptide and its sequence |
| 01/02/2013 | CN102850438A Solid phase preparation method of crude octrotide |
| 01/02/2013 | CN102850437A Histrelin synthesizing method |
| 01/02/2013 | CN102850436A Growth hormone releasing peptides |
| 01/02/2013 | CN102850435A Peptide vaccines for cancers expressing MPHOSP1 or DEPDC1 polypeptides |
| 01/02/2013 | CN102850434A Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
| 01/02/2013 | CN102850433A Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
| 01/02/2013 | CN102850432A Identification and application of non-ribosome antimicrobial peptide |
| 01/02/2013 | CN102850431A Chimeric peptide based on opioid peptide Biphalin and neuropeptide FF, its synthesis and application |
| 01/02/2013 | CN102060909B Tumor specific target polypeptide and application thereof |
| 01/02/2013 | CN101400692B Potent compstatin analogs |
| 01/02/2013 | CN101170994B 荷电的脂蛋白络合物及其用途 Charged lipoprotein complexes and their use |
| 01/01/2013 | US8344102 Nanoparticle and magnetic resonance imaging contrast agent |
| 01/01/2013 | US8344100 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity |
| 01/01/2013 | US8343931 Methods of inhibiting photoreceptor apoptosis |
| 01/01/2013 | US8343921 Method for treating myocardial ischemia |
| 01/01/2013 | US8343912 Antibiotic compositions for the treatment of gram negative infections |
| 01/01/2013 | US8343503 Contiguous overlapping peptides for treatment of birch pollen allergy |
| 01/01/2013 | US8343500 Peptide composition |
| 01/01/2013 | US8343496 Anti-CD74 immunoconjugates and methods |
| 01/01/2013 | US8343477 Viricides; serine protease inhibitors |
| 12/27/2012 | WO2012178063A1 Compound and method for modulating opioid receptor activity |
| 12/27/2012 | WO2012177770A1 Bipartite inhibitors of bacterial rna polymerase |
| 12/27/2012 | WO2012176909A1 Tripropeptin derivative or pharmacologically acceptable salt thereof, and antibacterial agent |
| 12/27/2012 | WO2012176879A1 Reagent for cancer testing, and cancer testing method |
| 12/27/2012 | WO2012176659A1 Production method for casein-derived peptides by lactic acid fermentation |
| 12/27/2012 | WO2012175532A1 Modified antibiotic peptides having variable systemic release |
| 12/27/2012 | WO2012175223A1 Cathepsin-binding compounds bound to a carrier and their diagnostic use |
| 12/27/2012 | WO2012137150A3 Cell penetrating peptides for intracellular delivery of molecules |
| 12/27/2012 | WO2012118972A3 Process of preparing guanylate cyclase c agonists |
| 12/27/2012 | WO2012107908A3 Nts-polyplex nanoparticles system for gene therapy of cancer |
| 12/27/2012 | WO2012075243A3 Methods and compositions for targeting sites of neovascular growth |
| 12/27/2012 | WO2012036437A9 Immunogenic peptide and composition having the peptide for preventing or treating hpv-related disease |
| 12/27/2012 | WO2012031250A3 Compositions for labeling nerves and methods of use |
| 12/27/2012 | US20120329986 Heteropeptides useful for reducing nonspecific adsorption |
| 12/27/2012 | US20120329730 Aromatic-cationic peptides and uses of same |
| 12/27/2012 | US20120329728 Compositions and methods for modulating gamma-c-cytokine activity |
| 12/27/2012 | US20120329721 Means for preventing and treating cellular death and their biological applications |
| 12/27/2012 | US20120329716 Yellow pea seed protein-derived peptides |
| 12/27/2012 | US20120328735 Process for preparing casein-derived peptides by fermentation of lactic acid bacteria |
| 12/27/2012 | US20120328692 Potent d-peptide antagonists of mdm2 and mdmx for anticancer therapy |
| 12/27/2012 | US20120328638 Mybl2 peptides and vaccines containing the same |
| 12/27/2012 | US20120328636 Kdr peptides and vaccines comprising the same |
| 12/27/2012 | US20120328534 Enzymatic peracid generation for use in oral care products |
| 12/27/2012 | US20120328512 Fibrin-Binding Peptides and Conjugates Thereof |
| 12/27/2012 | DE102011118031A1 New calicivirus binding peptide, useful for enriching, immobilizing, detecting and/or marking caliciviruses, and for treating viral infection, preferably calicivirus infection or norovirus infection |
| 12/27/2012 | DE102009021681B4 Verwendung von Staphylococcus aureus bindenden Peptiden, Verfahren und Kits zur Anreicherung, Immobilisierung und zum Nachweis von Staphylococcus aureus, Staphylococcus aureus bindendes Peptid und dafür kodierende Nukleinsäure Use of Staphylococcus aureus binding peptides, methods and kits for the enrichment, immobilization and detection of Staphylococcus aureus, Staphylococcus aureus binding peptide and nucleic acid coding therefor |
| 12/27/2012 | CA2839024A1 Modified antibiotic peptides having variable systemic release |
| 12/26/2012 | EP2537856A1 Method for preparing atosiban acetate |
| 12/26/2012 | EP2537834A2 Polyazamacrocyclic compound, and a production method and a biomedical use therefor |
| 12/26/2012 | EP2537532A1 Cathepsin-binding compounds bound to a nanodevice and their diagnostic and therapeutic use |
| 12/26/2012 | EP2536742A2 Treatments for gastrointestinal disorders |
| 12/26/2012 | EP2536741A2 Gene fusion targeted therapy |
| 12/26/2012 | CN102844327A Template-fixed peptidomimetics with cxcr7 modulating activity |
| 12/26/2012 | CN102838660A Small molecule polypeptides with function of inflammation immune reaction inhibition, and applications thereof |
| 12/26/2012 | CN102838659A Plasmodium vivax antigen polypeptide, IgY antibody, and application thereof in malaria diagnosis |
| 12/26/2012 | CN102838658A Treatment of inflammation and/or endotoxic shock |